Healthcare & Life Sciences
Stingray Therapeutics
United Statesstingraytx.com/
Stingray Therapeutics is a Healthcare & Life Sciences startup based in the United States.
About Stingray Therapeutics
Stingray Therapeutics is a startup based in the United States. Brouky classifies it under Healthcare & Life Sciences.
Stingray Therapeutics is a clinical-stage biotech developing Vizenpistat (SR-8541A), a small-molecule ENPP1 inhibitor designed to reactivate innate immunity via the cGAS‑STING pathway for cancer immunotherapy; the program is in Phase 1 and Phase 1b/2 trials across multiple solid tumor indications.
Explore Stingray Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.